Recombinant Archaeoglobus fulgidus Adenosylhomocysteinase (ahcY)

Shipped with Ice Packs
In Stock

Description

Enzyme Overview

Recombinant Archaeoglobus fulgidus Adenosylhomocysteinase (UniProt ID: O28279) catalyzes the reversible hydrolysis of S-adenosylhomocysteine (SAH) into adenosine (Ado) and homocysteine (Hcy). This reaction is essential for maintaining cellular methylation balance by regulating SAH levels, a potent inhibitor of methyltransferases .

Key Features:

  • Thermostability: As A. fulgidus is a hyperthermophilic archaeon, its recombinant AHCY likely retains activity at high temperatures, a trait advantageous for industrial applications .

  • Cofactor Dependency: Binds NAD+ tightly, a conserved feature across AHCY homologs, which stabilizes the enzyme’s structure and mediates redox reactions during catalysis .

  • Quaternary Structure: Expected to form a homotetramer, similar to human and bacterial variants .

Research Applications and Implications

  1. Biotechnological Uses:

    • Methylation Studies: Recombinant A. fulgidus AHCY could serve as a stable tool for in vitro methylation assays, particularly under high-temperature conditions .

    • Homocysteine Regulation: Potential use in metabolic disorder research, given its role in Hcy production—a biomarker for cardiovascular diseases .

  2. Pathological Insights:

    • Mutations in human AHCY cause hypermethioninemia and vascular dysfunction . Studying the archaeal enzyme’s resilience to destabilizing mutations (e.g., p.Asp86Gly in humans ) may inform therapeutic strategies.

  3. Evolutionary Significance:

    • AHCY’s conservation across domains of life underscores its fundamental role in one-carbon metabolism. A. fulgidus AHCY provides a model for studying enzyme adaptation to extreme environments .

Future Directions

  • Structural Characterization: X-ray crystallography or cryo-EM of recombinant A. fulgidus AHCY could elucidate thermostability mechanisms.

  • Industrial Enzymology: Explore its utility in high-temperature biocatalysis or SAM-dependent synthetic pathways.

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us.
Synonyms
ahcY; AF_2000; Adenosylhomocysteinase; EC 3.3.1.1; S-adenosyl-L-homocysteine hydrolase; AdoHcyase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-405
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)
Target Names
ahcY
Target Protein Sequence
MEGFRKIEWA ERYMKVLGKI REQFRKERPL EGFTVGMALH VEAKTAVLVR TLVDAGAEVA ITGCNPMSTQ DDVADALRES GIACYAKRGM DVEEYYEALR NVIRAEPDIV IDDGADLIFL LHGEMESYAE KVKGASEETT TGVIRLRAME REGVLKFPVI AVNDAYTKYL FDNRYGTGQS AIDGVIRATN LLMAGKIVVV AGYGWCGRGI AMRARGMGAS VVVTEVDEIR ALEAVMDGFR VMRMEDAAKI GDIFITATGN RDIIREEHIR LMKDGAILAN AGHFNVEIDI PALERMAKAK REARKYVTEY DLGDKRVYLL AEGRLVNLVA ADGHPVEVMD MSFANQALAA KYIAENWQKL ERKVYRLPEE LDRMVARMKL ESMGVEIDQL TEEQVRYLSD WRCGT
Uniprot No.

Target Background

Function
May play a key role in regulating intracellular adenosylhomocysteine concentration.
Database Links

KEGG: afu:AF_2000

STRING: 224325.AF2000

Protein Families
Adenosylhomocysteinase family
Subcellular Location
Cytoplasm.

Q&A

What is Archaeoglobus fulgidus Adenosylhomocysteinase (AHCY) and what role does it serve in cellular metabolism?

Adenosylhomocysteinase (AHCY) from Archaeoglobus fulgidus is an enzyme that catalyzes the hydrolysis of S-adenosylhomocysteine (SAH) to adenosine and L-homocysteine. This reaction is critical in the methylation cycle, as SAH is a potent product inhibitor of S-adenosylmethionine (SAM)-dependent methyltransferases. The removal of SAH by AHCY is essential for maintaining methylation reactions within the cell. In A. fulgidus, a hyperthermophilic archaeon that grows optimally around 80°C, this enzyme has evolved structural features that confer exceptional thermostability while maintaining catalytic function at elevated temperatures .

What expression systems are most effective for producing recombinant A. fulgidus AHCY?

Recombinant A. fulgidus AHCY has been successfully expressed in multiple heterologous systems:

  • Yeast expression system: This has proven to be an economical and efficient eukaryotic system for expression. The yeast system can provide post-translational modifications that more closely resemble the native protein state .

  • E. coli expression system: This is commonly used for archaeal proteins, though expression may be improved by co-expressing the E. coli dnaY gene, which encodes arginyl tRNA for the rare codons AGA and AGG. This strategy has been successfully employed for other A. fulgidus proteins, such as D-lactate dehydrogenase .

  • Baculovirus-infected insect cells: Although more costly, this system can provide higher quality protein with eukaryotic post-translational modifications .

The choice of expression system should be based on the specific research needs, considering factors such as required protein purity, post-translational modifications, and cost constraints.

What purification strategies yield the highest quality recombinant A. fulgidus AHCY?

Purification of recombinant A. fulgidus AHCY typically involves a multi-step process:

  • Affinity chromatography: For His-tagged proteins, immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar resins is the primary purification step. The protein is typically eluted with increasing concentrations of imidazole .

  • Heat treatment: Given the thermostable nature of A. fulgidus proteins, a heat treatment step (70-80°C for 15-30 minutes) can significantly improve purity by denaturing most host cell proteins while leaving the target protein intact.

  • Size exclusion chromatography: This can be employed as a polishing step to remove aggregates and obtain highly pure protein.

  • Tag removal: If necessary, the His-tag can be removed using specific proteases such as factor Xa, similar to the approach used with other A. fulgidus recombinant proteins .

The purified protein typically achieves >90% purity as determined by SDS-PAGE and maintains its native oligomeric state, which for A. fulgidus AHCY is reported to be dimeric .

How do researchers determine the enzymatic activity of recombinant A. fulgidus AHCY?

The enzymatic activity of recombinant A. fulgidus AHCY can be assessed using several complementary approaches:

  • Spectrophotometric assays: These monitor the hydrolysis of S-adenosylhomocysteine (SAH) to adenosine and homocysteine. The most common methods include:

    • Coupling with adenosine deaminase to measure the conversion of adenosine to inosine (decrease in absorbance at 265 nm)

    • Ellman's reagent (DTNB) to detect the free thiol group of homocysteine

  • Chromatographic methods: HPLC analysis can be used to quantify substrate depletion and product formation.

  • High-temperature adaptations: Given the thermophilic nature of the enzyme, assays may need to be conducted at elevated temperatures (70-80°C) using specialized equipment and sealed reaction vessels to prevent evaporation.

How can site-directed mutagenesis be effectively employed to investigate the catalytic mechanism of A. fulgidus AHCY?

Site-directed mutagenesis represents a powerful approach for investigating the catalytic mechanism of A. fulgidus AHCY:

  • Selection of target residues:

    • Identify conserved catalytic residues through multiple sequence alignments with well-characterized AHCY homologs

    • Focus on regions homologous to known active sites in other AHCY enzymes

    • Target residues unique to thermophilic AHCYs that may contribute to thermostability

  • Experimental design:

    • Generate single amino acid substitutions using PCR-based mutagenesis techniques

    • Express and purify mutant proteins using identical conditions to wild-type

    • Compare kinetic parameters (KM, kcat, kcat/KM) between wild-type and mutant enzymes

    • Assess thermostability changes using thermal shift assays

  • Data interpretation:

    • Correlate activity changes with specific amino acid functions

    • Develop a mechanistic model based on mutational effects

    • Compare findings with known mechanisms from mesophilic AHCY enzymes

This approach has been successfully applied to other A. fulgidus enzymes, such as ATP sulfurylase, to elucidate their catalytic mechanisms .

What methodological considerations are important when conducting enzyme kinetics studies with A. fulgidus AHCY at elevated temperatures?

Studying enzyme kinetics at the high temperatures required for optimal A. fulgidus AHCY activity presents several unique challenges:

  • Reaction vessel considerations:

    • Use sealed, pressure-resistant containers to prevent evaporation

    • Ensure uniform temperature distribution within the reaction vessel

    • Pre-equilibrate all components to the target temperature

  • Buffer stability:

    • Select buffers with minimal temperature-dependent pH changes (e.g., phosphate or HEPES)

    • Account for changes in pKa values at elevated temperatures

    • Check for buffer compatibility with assay components at high temperatures

  • Substrate and product stability:

    • Verify thermal stability of substrates and products under assay conditions

    • Account for potential non-enzymatic degradation or side reactions

    • Consider using shorter reaction times to minimize these effects

  • Experimental design:

    • Include appropriate controls for thermal denaturation of the enzyme

    • Measure initial reaction rates to avoid complications from product inhibition or substrate depletion

    • Collect data across a range of temperatures to determine temperature optima and activation energies

How does A. fulgidus AHCY compare structurally and functionally to homologs from mesophilic organisms?

Comparative analysis between A. fulgidus AHCY and its mesophilic counterparts reveals several important differences:

FeatureA. fulgidus AHCYMesophilic AHCY (e.g., Human)
Sequence length405 amino acids432 amino acids
Temperature optimum~80°C37°C
Oligomeric stateHomo-dimerHomo-tetramer
StabilityResistant to thermal denaturation up to 80°CDenaturation typically occurs above 45°C
Surface charge distributionHigher proportion of charged residuesLower density of charged residues

The A. fulgidus enzyme has likely evolved specific adaptations for function at high temperatures while maintaining the core catalytic mechanism conserved across all AHCY enzymes. Similar evolutionary patterns have been observed in other A. fulgidus enzymes, such as ATP sulfurylase, which shows homology to sulfur-oxidizing bacteria while adapting to extreme conditions .

What insights can be gained from studying A. fulgidus AHCY about the evolution of thermostable enzymes?

The study of A. fulgidus AHCY provides valuable insights into evolutionary adaptation to extreme environments:

  • Convergent vs. divergent evolution: Comparing AHCY from different thermophilic organisms can reveal whether similar adaptations evolved independently or from a common thermophilic ancestor.

  • Trade-offs between stability and activity: Analysis of catalytic efficiency across temperature ranges can illuminate how thermostability adaptations may affect catalytic performance.

  • Domain-specific adaptation: Determining whether certain domains or regions show more thermostability-related modifications than others.

  • Evolutionary rate analysis: Examining whether thermophilic adaptations accumulate gradually or through periodic selective sweeps.

Researchers can employ evolutionary rate analysis, ancestral sequence reconstruction, and comparative genomics approaches to address these questions. Distance matrix analyses, similar to those performed for A. fulgidus ATP sulfurylase, can provide insights into the evolutionary relationships between archaeal enzymes and their bacterial or eukaryotic counterparts .

How can recombinant A. fulgidus AHCY be utilized in biotechnological applications requiring thermostable enzymes?

The exceptional thermostability of A. fulgidus AHCY makes it valuable for various biotechnological applications:

  • Biocatalysis at elevated temperatures:

    • Integration into multi-enzyme cascade reactions where high temperatures improve reaction rates or substrate solubility

    • Applications in processes requiring the removal of S-adenosylhomocysteine to drive methylation reactions

    • Use in continuous flow processes where thermostability extends catalyst lifespan

  • Analytical applications:

    • Development of thermostable biosensors for detecting methylation-related metabolites

    • Component in high-temperature analytical processes for detecting SAH

    • Use in assays for methyltransferase activity where AHCY prevents product inhibition

  • Protein engineering platform:

    • As a scaffold for engineering thermostable variants of other enzymes

    • For studying fundamental principles of protein thermostability

    • Template for computational design of thermostable biocatalysts

  • Implementation strategies:

    • Immobilization on solid supports for enhanced stability and reusability

    • Integration with thermostable cofactor regeneration systems

    • Protein engineering to modify substrate specificity or other properties

What are the current limitations in working with recombinant A. fulgidus AHCY and how might they be overcome?

Despite its potential, several challenges exist when working with recombinant A. fulgidus AHCY:

  • Expression challenges:

    • Codon bias issues when expressing in heterologous hosts

    • Solution: Use codon-optimized genes or co-express rare tRNAs, such as the E. coli dnaY gene for rare arginine codons

  • Assay development:

    • Difficulty maintaining high temperatures uniformly in standard laboratory equipment

    • Solution: Develop specialized reaction vessels or adapt existing equipment with precise temperature control

  • Substrate limitations:

    • Limited commercial availability of S-adenosylhomocysteine and related compounds

    • Solution: Develop enzymatic or chemical synthesis methods for substrates

  • Compatibility with other enzymes:

    • Temperature incompatibility when attempting to couple with mesophilic enzymes

    • Solution: Engineer thermostable variants of partner enzymes or develop uncoupled assay methods

  • Scale-up challenges:

    • Maintaining optimal conditions at larger scales

    • Solution: Develop specialized bioreactors with precise temperature control and efficient mixing

By addressing these limitations through innovative approaches and technological developments, the full potential of A. fulgidus AHCY can be realized in both research and biotechnological applications.

What are the key unresolved questions about A. fulgidus AHCY that warrant further investigation?

Several important questions about A. fulgidus AHCY remain to be addressed:

  • Detailed structural characterization: High-resolution crystal structures of A. fulgidus AHCY in various ligand-bound states would provide crucial insights into its catalytic mechanism and the structural basis of thermostability.

  • Regulatory mechanisms: Investigation of potential allosteric regulation and how it may differ from mesophilic homologs.

  • Physiological role: Detailed understanding of how AHCY function integrates with broader metabolic networks in A. fulgidus, particularly in relation to sulfur metabolism, which is central to this organism's energy production .

  • Evolutionary history: More comprehensive phylogenetic analysis to determine the evolutionary trajectory of this enzyme and its relationship to homologs from other extremophiles.

  • Structure-function relationships: Systematic mutagenesis studies to identify specific residues contributing to thermostability versus catalytic activity.

What emerging technologies might enhance our understanding of A. fulgidus AHCY?

Several cutting-edge technologies show promise for advancing our understanding of this enzyme:

  • Cryo-electron microscopy (cryo-EM): Could reveal high-resolution structures without the need for crystallization.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): To probe protein dynamics and conformational changes under various conditions.

  • Single-molecule enzymology: To examine kinetic heterogeneity and conformational dynamics at high temperatures.

  • Computational approaches:

    • Molecular dynamics simulations at elevated temperatures

    • Machine learning-based prediction of thermostability determinants

    • Quantum mechanics/molecular mechanics (QM/MM) calculations to elucidate catalytic mechanisms

  • Synthetic biology tools: Development of genetic manipulation systems for A. fulgidus would enable in vivo studies of AHCY function and regulation.

By integrating these emerging technologies with established biochemical and structural approaches, researchers can develop a more comprehensive understanding of this fascinating thermostable enzyme and its potential applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.